Table 1.
Method | TWIST |
Toxicity |
Relapse |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Observation |
Vinorelbine and Cisplatin |
Observation |
Vinorelbine and Cisplatin |
Observation |
Vinorelbine and Cisplatin |
|||||||
Weight | SD | Weight | SD | Weight | SD | Weight | SD | Weight | SD | Weight | SD | |
1. Arbitrary values | 1 | 1 | — | — | 0.75 | 0.50 | 0.50 | |||||
2. Global questions QLQ-C30 | 1 | 1 | — | — | 0.57 | 0.21 | 0.50 | 0.25 | 0.50 | 0.25 | ||
3. Symptom-related questions QLQ-C30 | 1 | 1 | — | — | 0.86 | 0.09 | 0.83 | 0.10 | 0.83 | 0.10 | ||
4. EQ5D index score* | 0.75 | 0.75 | — | — | 0.68 | 0.60 | 0.60 |
Abbreviations: TWIST, time without symptoms or toxicity; SD, standard deviation; QLQ-C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30; EQ5D, European Quality of Life–Five Dimensions questionnaire.